Stem-Fenix Bio-Intelligence & Therapeutics Private Limited
Founded: 2014
Status: Strike Off
Designation: Director
Chandan Dhondiram Sabale - Profile
Chandan Dhondiram Sabale, Director, with 4 companies across 2 industries.
About
Chandan Dhondiram Sabale
Chandan Dhondiram Sabale has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including Stem-Fenix Bio-Intelligence & Therapeutics Private Limited and Sakkalp Health By Nutrition Private Limited. Formerly with 2 companies, such as Genavli Lifesciences Private Limited and Stemreg-X Bio-Intelligence & Therapeutics Private Limited. Engaged in General Business, Healthcare.
Current Companies
2
Past Companies
2
Total Affiliations
4
Oldest Company Age
11
Companies Associated with Chandan Dhondiram Sabale
Current Companies
Sakkalp Health By Nutrition Private Limited
Founded: 2023
Status: Active
Designation: Director
Previous Companies
Genavli Lifesciences Private Limited
Founded: 2024
Status: Active
Designation: Director
Stemreg-X Bio-Intelligence & Therapeutics Private Limited
Founded: 2016
Status: Active
Designation: Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Chandan Dhondiram Sabale?
Chandan Dhondiram Sabale has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including Stem-Fenix Bio-Intelligence & Therapeutics Private Limited and Sakkalp Health By Nutrition Private Limited. Formerly with 2 companies, such as Genavli Lifesciences Private Limited and Stemreg-X Bio-Intelligence & Therapeutics Private Limited. Engaged in General Business, Healthcare.
What is Chandan Dhondiram Sabale's role in current companies?
Chandan Dhondiram Sabale is associated with 2 companies as Director.
What industries does Chandan Dhondiram Sabale specialize in?
Chandan Dhondiram Sabale has expertise in General Business, Healthcare.
How many years of experience does Chandan Dhondiram Sabale have?
Chandan Dhondiram Sabale has 11 years in corporate governance.